What is THINKMD?
Headquartered in Burlington, Vermont, and founded in 2014 by pediatricians, THINKMD develops AI-powered clinical intelligence platforms designed to empower healthcare workers with medically validated assessment capabilities, irrespective of their training level. The company leverages machine learning to analyze clinical data via a mobile application, offering dynamic evaluations akin to physician assessments. This technology functions both online and offline, providing critical insights into patient conditions, potential illnesses, and recommended next steps. THINKMD's platform also supports population health monitoring and disease surveillance, serving global health organizations such as Save the Children and Healthy Learners.
How much funding has THINKMD raised?
THINKMD has raised a total of $6.3M across 2 funding rounds:
Grant
$2.3M
Unspecified
$4M
Grant (2021): $2.3M with participation from Bill & Melinda Gates Foundation
Unspecified (2021): $4M, investors not publicly disclosed
Key Investors in THINKMD
Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation is a global organization dedicated to improving health and reducing poverty, known for its significant investments in public health initiatives and medical research worldwide.
What's next for THINKMD?
With its recent major strategic investment and substantial overall capital, THINKMD is poised for significant expansion and further development of its AI-driven healthcare solutions. The company's focus on enhancing healthcare capacity and evolving delivery models, especially in low and middle-income countries, positions it for continued growth. Future initiatives will likely involve scaling its platform's reach, deepening its analytical capabilities, and forging new partnerships to address critical global health challenges and improve clinical outcomes through data-driven insights.
See full THINKMD company page
